TENAX THERAPEUTICS, INC. Gain (Loss) on Extinguishment of Debt
TENAX THERAPEUTICS, INC. (TENX) reported Gain (Loss) on Extinguishment of Debt of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2023-03-31
- TENAX THERAPEUTICS, INC. gain (loss) on extinguishment of debt for the quarter ending 2021-12-31 was -$494.47K.
- TENAX THERAPEUTICS, INC. gain (loss) on extinguishment of debt for the quarter ending 2021-09-30 was $0.00.
- TENAX THERAPEUTICS, INC. gain (loss) on extinguishment of debt for the quarter ending 2020-12-31 was $0.00.
- TENAX THERAPEUTICS, INC. gain (loss) on extinguishment of debt for the quarter ending 2020-09-30 was $0.00.
- TENAX THERAPEUTICS, INC. gain (loss) on extinguishment of debt for fiscal 2022 was $0.00.
- TENAX THERAPEUTICS, INC. gain (loss) on extinguishment of debt for fiscal 2021 was -$247.23K.
- TENAX THERAPEUTICS, INC. gain (loss) on extinguishment of debt for fiscal 2020 was $0.00.
- TENAX THERAPEUTICS, INC. gain (loss) on extinguishment of debt for fiscal 2012 was $0.00.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 6 month as first filed | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 9 month as first filed | Gain (Loss) on Extinguishment of Debt 12 month | Gain (Loss) on Extinguishment of Debt 12 month as first filed | Gain (Loss) on Extinguishment of Debt 530 month | Gain (Loss) on Extinguishment of Debt 533 month | Gain (Loss) on Extinguishment of Debt 536 month | Gain (Loss) on Extinguishment of Debt 539 month | Gain (Loss) on Extinguishment of Debt 542 month | Gain (Loss) on Extinguishment of Debt 545 month | Gain (Loss) on Extinguishment of Debt 554 month | Gain (Loss) on Extinguishment of Debt 557 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-31 | ||||||||||||||
| 2021-12-31 | -$494.47K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$494.47K derived: sum of 2 quarters · filed 2023-03-31 | -$247.23K 10-K · filed 2023-03-31 | $247.23K 10-K · filed 2022-03-29 | |||||||||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $247.23K 10-Q · filed 2022-11-10 | -$247.23K 10-Q · filed 2021-11-15 | ||||||||||||
| 2021-06-30 | $247.23K 10-Q · filed 2022-08-11 | -$247.23K 10-Q · filed 2021-08-16 | |||||||||||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $0.00 derived: sum of 2 quarters · filed 2022-03-29 | $0.00 10-K · filed 2022-03-29 | ||||||||||||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $0.00 10-Q · filed 2021-11-15 | |||||||||||||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-16 | ||||||||||||||
| 2014-01-31 | $0.00 10-Q · filed 2014-03-17 | $0.00 derived: sum of 2 quarters · filed 2014-03-17 | $0.00 10-Q · filed 2014-03-17 | -$250.10K 10-Q · filed 2014-03-17 | |||||||||||
| 2013-10-31 | $0.00 10-Q · filed 2013-12-17 | $0.00 10-Q · filed 2013-12-17 | -$250.10K 10-Q · filed 2013-12-17 | ||||||||||||
| 2013-07-31 | -$250.10K 10-Q · filed 2013-09-17 | ||||||||||||||
| 2013-04-30 | -$250.10K 10-K · filed 2013-06-26 | ||||||||||||||
| 2013-01-31 | $0.00 10-Q · filed 2014-03-17 | $0.00 derived: sum of 2 quarters · filed 2014-03-17 | $0.00 10-Q · filed 2014-03-17 | -$250.10K 10-Q · filed 2013-03-18 | |||||||||||
| 2012-10-31 | $0.00 10-Q · filed 2013-12-17 | $0.00 10-Q · filed 2013-12-17 | -$250.10K 10-Q · filed 2012-12-14 | ||||||||||||
| 2012-07-31 | -$250.10K 10-Q · filed 2012-09-19 | ||||||||||||||
| 2012-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-25 | $0.00 derived: sum of 2 quarters · filed 2012-07-25 | $0.00 derived: sum of 3 quarters · filed 2012-07-25 | $0.00 10-K · filed 2012-07-25 | $250.10K 10-K · filed 2012-07-25 | ||||||||||
| 2012-01-31 | $0.00 10-Q · filed 2012-03-15 | $0.00 derived: sum of 2 quarters · filed 2012-03-15 | $0.00 10-Q · filed 2012-03-15 | $0.00 derived: sum of 4 quarters · filed 2012-07-25 | $250.10K 10-Q · filed 2012-03-15 | ||||||||||
| 2011-10-31 | $0.00 10-Q · filed 2011-12-15 | $0.00 10-Q · filed 2011-12-15 | $0.00 derived: sum of 3 quarters · filed 2012-07-25 | $0.00 derived: sum of 4 quarters · filed 2012-07-25 | $250.10K 10-Q · filed 2011-12-15 | ||||||||||
| 2011-07-31 | $0.00 10-Q · filed 2011-09-19 | $0.00 derived: sum of 2 quarters · filed 2012-07-25 | $0.00 derived: sum of 3 quarters · filed 2012-07-25 | $0.00 derived: sum of 4 quarters · filed 2012-07-25 | $250.10K 10-Q · filed 2011-09-19 | ||||||||||
| 2011-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-25 | $0.00 derived: sum of 2 quarters · filed 2012-07-25 | $0.00 derived: sum of 3 quarters · filed 2012-07-25 | $0.00 10-K · filed 2012-07-25 | |||||||||||
| 2011-01-31 | $0.00 10-Q · filed 2012-03-15 | $0.00 derived: sum of 2 quarters · filed 2012-03-15 | $0.00 10-Q · filed 2012-03-15 | ||||||||||||
| 2010-10-31 | $0.00 10-Q · filed 2011-12-15 | $0.00 10-Q · filed 2011-12-15 | |||||||||||||
| 2010-07-31 | $0.00 10-Q · filed 2011-09-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |